Skip to content

The Eyes Have it : Ocular Saccade Abnormalities in Prodromal Alzheimer's Disease

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01630525
Acronym
LYLO
Enrollment
83
Registered
2012-06-28
Start date
2012-12-31
Completion date
2015-12-31
Last updated
2016-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer's Disease

Keywords

Alzheimer's disease, neurodegenerative signs

Brief summary

Alzheimer's disease (AD) has a prolonged prodromal phase before the stage of dementia. Subtle executive cognitive function deficits can be detected at this early pre-dementia phase, more than 10 years before dementia. Among them, the digit symbol substitution task (DSST) has been shown to be altered very early, up to 13 years before dementia. This test, as many others executive function tests, requires a fine control of visuomotor coordination. Like executive functions, eye movements, particularly voluntary-guided saccades, are under the control of the frontal lobe and fronto-parietal networks. Previous studies have shown a deterioration of voluntary saccades in AD using various paradigms. There are no data in prodromal AD, although the pathological process of the disease affects very early brain structures implicated in saccades execution (eg. caudate nucleus and pre-cuneus).

Interventions

OTHERNeuropsychological assessment

Neuropsychological assessment : MMSE (Greco), RL/RI-16 items (Van der Linden 2003), visual retention test (DMS48), verbal fluency (Thurstone et Thurstone 1964), TMT A and B (Reitan 1956), DSST (Weschler 1997), Clinical Dementia Rating Scale (Hughes 1982), image naming DO80 (Deloche et Hannequin 1997), Similarities and Digit Span subscores of the WAIS (Weschler 1997), Anxiety and Depression (GDS), activities of daily living (ADL-Katz and IADL-Lawton).

OTHERophthalmologic checkup

Vision work-up, 30 minutes (VA, non invasive retinal imaging : non dilated optic fundus picture or OCT, ocular tension).

OTHERAutomated non-invasive oculometry

Automated non-invasive oculometry : 45 minutes with rest periods : horizontal and vertical pro- and anti-saccades, prediction, spatial decision (Monsiman et al. Brain 2005,128:1267-127, items detection (Rösler et al. Cortex 2005 ;41 :512-519) and exploration/curiosity of non congruent images and faces according to Daffner et al. Neurology 1992 ;42 :320-328 and Loughland et al. Biol Psychiatry 2002 ;52 : 338-348).

Sponsors

University Hospital, Bordeaux
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

All patient groups: * Age \>60 years * Normal vision work-up : (corrected binocular visual acuity \> 8/10) * Written informed consent * Subjects affiliated to Social Security Group A: Prodromal AD. * Memory complaints. * Normal or slight restriction of IADL. * hippocampal-type amnesic syndrome defined by poor free recall despite adequate (and controlled) encoding, decreased total recall because of insufficient effect of cuing or impaired recognition, numerous intrusions (RL/RI-16items) * CDR (Clinical Dementia Rating Scale) ≥ 0,5 * Persistence of memory changes at a subsequent assessment (\>3 months) * Absence of global cognitive deterioration (MMSE ≥24) * Exclusion of other disorders that may cause mild cognitive impairment with adequate tests * 1.5 Tesla diagnosis MRI with at least T2, Flair transversal sections and coronal T1 sections in the coronal plan. Absent or slight medio temporal/hippocampal atrophy or if available (non mandatory) characteristic CSF betaA42/tau ratio Group B: Typical AD (mild to moderate) * NINDS-ADRDA diagnosis criteria * MMSE ≥ 20 Group C: Control subjects * No memory or other significant cognitive complain. * MMSE ≥ 24

Exclusion criteria

All groups : * Clinically significant vision abnormality(P8 without glasses) * Oculomotor deficit or strabismus * Depression (GDS) with treatment * Subjects unable to give their informed consent Controls : * Memory or any other significant cognitive complain. * Abnormalities at inclusion (V0) neuropsychology testing suggestive of a cognitive deficit.

Design outcomes

Primary

MeasureTime frameDescription
Saccades execution parametersStudy visit (Up to 1 month after inclusion)To demonstrate the alteration of saccade execution parameters (latency, velocity, precision, errors) during pro and anti-saccades, spatial decision and prediction tasks in prodromal AD compared to mild to moderate AD and aged-matched controls. Variables recorded : Saccades execution parameters : * Mean latency (msec), * Mean velocity (°/msec) and maximal velocity, * Accuracy or mean gain, * Mean percent of errors and corrected errors, * Mean percent of prediction.

Secondary

MeasureTime frame
Neuropsychology tests scoresAt inclusion (Day 0)
Pre-defined variables on visual exploration tasks (fixation number and durations, errors).Study visit (Up to 1 month after inclusion)
Number of point fixation in degraded areas and of visual attention induced cardsStudy visit (Up to 1 month after inclusion)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026